あすか製薬ホールディングス(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4886/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/06/03 | 日証協 | 139,341株 | -8.73% | 57,000株 | +42.14% | 211,031株 | -1.31% | 43,597株 | -58.96% |
2022/05/27 | 日証協 | 152,661株 | -11.33% | 40,100株 | +78.22% | 213,831株 | +1.18% | 106,226株 | +104.51% |
2022/05/20 | 日証協 | 172,161株 | +7.27% | 22,500株 | +127.99% | 211,331株 | +5.34% | 51,941株 | +9.75% |
2022/05/13 | 日証協 | 160,492株 | -1.41% | 9,869株 | +3.88% | 200,616株 | -1.62% | 47,326株 | +484.27% |
2022/05/06 | 日証協 | 162,792株 | -6.49% | 9,500株 | +352.38% | 203,917株 | -5.92% | 8,100株 | -71.46% |
2022/04/28 | 日証協 | 174,092株 | +1.87% | 2,100株 | -91.6% | 216,750株 | +1.98% | 28,380株 | -52.4% |
2022/04/22 | 日証協 | 170,892株 | +15.4% | 25,000株 | -28.57% | 212,550株 | +8.03% | 59,626株 | +91.03% |
2022/04/15 | 日証協 | 148,092株 | +24.47% | 35,000株 | -38.03% | 196,750株 | -2.14% | 31,213株 | -4.26% |
2022/04/08 | 日証協 | 118,976株 | +8.95% | 56,478株 | -59.23% | 201,054株 | -7.03% | 32,602株 | -86.37% |
2022/04/01 | 日証協 | 109,206株 | -22% | 138,517株 | +139.36% | 216,252株 | -17.03% | 239,230株 | +661.25% |
2022/03/25 | 日証協 | 140,006株 | +11.53% | 57,869株 | -62.27% | 260,647株 | -3.63% | 31,426株 | -75.77% |
2022/03/18 | 日証協 | 125,537株 | +101.38% | 153,365株 | +182.1% | 270,472株 | +21.73% | 129,700株 | +170.77% |
2022/03/11 | 日証協 | 62,337株 | +59.54% | 54,365株 | +20.81% | 222,181株 | +0.86% | 47,900株 | +97.12% |
2022/03/04 | 日証協 | 39,072株 | -31.87% | 45,000株 | +61.87% | 220,281株 | -12.68% | 24,300株 | -15.04% |
2022/02/25 | 日証協 | 57,345株 | +22.94% | 27,800株 | -63.11% | 252,281株 | -0.2% | 28,601株 | +54.58% |
2022/02/18 | 日証協 | 46,645株 | -51.29% | 75,365株 | +30.62% | 252,781株 | -19% | 18,502株 | -32.56% |
2022/02/10 | 日証協 | 95,770株 | -14.39% | 57,700株 | -61.19% | 312,058株 | -6.08% | 27,436株 | -65.09% |
2022/02/04 | 日証協 | 111,870株 | +48.61% | 148,665株 | +75.16% | 332,245株 | +13.18% | 78,600株 | +152.19% |
2022/01/28 | 日証協 | 75,277株 | -15.33% | 84,873株 | +58.35% | 293,544株 | +1.97% | 31,167株 | +40.39% |
※株式分割は考慮していませんのでご注意ください。
Page Top